Global Hepatitis C Treatment Market to Grow at 8% CAGR by 2013
With the launch of new protease inhibitors and improved market penetration, the global Hepatitis C Treatment market is anticipated to grow at a CAGR of 8% during 2011-2013, says RNCOS in its latest research study.
View full press release